Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resected Pancreatic Adenocarcinoma”

132 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 132 results

Not applicableStudy completedNCT06344299
What this trial is testing

Predictors for Low Rates of Surgical Resection in Elderly Patients With Resectable Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Fudan University 5,302
Very early researchNot Yet RecruitingNCT06156267
What this trial is testing

Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino

Who this might be right for
Pancreatic Cancer
Fudan University 30
Testing effectiveness (Phase 2)Looking for participantsNCT05968326
What this trial is testing

The Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC

Who this might be right for
Adenocarcinoma, Pancreatic Ductal
Genentech, Inc. 260
Not applicableUnknownNCT04245410
What this trial is testing

Surgical Treatment of Pancreatic Metastases From Renal Cell Carcinoma

Who this might be right for
Surgical ProcedureDisease Free SurvivalOverall Survival
Universidad de Extremadura 100
Testing effectiveness (Phase 2)Study completedNCT02261714
What this trial is testing

Antigen-specific Cancer Immunotherapy (TG01) and Gemcitabine as Adjuvant Therapy in Resected Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Resected
Targovax ASA 32
Testing effectiveness (Phase 2)Study completedNCT02022033
What this trial is testing

BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial

Who this might be right for
Pancreatic Cancer
Brown University 25
Not applicableLooking for participantsNCT06574620
What this trial is testing

Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment

Who this might be right for
Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic Ductal Adenocarcinoma+1 more
British Columbia Cancer Agency 200
Early research (Phase 1)Ended earlyNCT00003434
What this trial is testing

Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Duke University 8
Testing effectiveness (Phase 2)Ended earlyNCT03469258
What this trial is testing

Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Dana-Farber Cancer Institute 4
Not applicableStudy completedNCT04802993
What this trial is testing

Survival Among Patients With Pancreatic Cancer Depending on Surgical Resection Rate

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Linkoeping University 5,123
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Large-scale testing (Phase 3)UnknownNCT02514928
What this trial is testing

Resection of the Nerve Plexus on the Right Half of Celiac and SMA Associated With Extended Pancreatoduodenectomy in the Surgical Treatment for Adenocarcinoma of the Head of Pancreas

Who this might be right for
Pancreatic Cancer
Fudan University 430
Testing effectiveness (Phase 2)Active Not RecruitingNCT01088789
What this trial is testing

Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 71
Testing effectiveness (Phase 2)Ended earlyNCT00766636
What this trial is testing

Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 5
Early research (Phase 1)Study completedNCT03885284
What this trial is testing

Study of Proton Therapy in Adjuvant Pancreatic Cancer

Who this might be right for
Resected Pancreatic Adenocarcinoma
Georgetown University 9
Testing effectiveness (Phase 2)Study completedNCT01553019
What this trial is testing

Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Florida 2
Testing effectiveness (Phase 2)UnknownNCT02754180
What this trial is testing

Adjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph Nodes

Who this might be right for
Pancreatic Neoplasms
Peking Union Medical College Hospital 110
Early research (Phase 1)Study completedNCT01456585
What this trial is testing

Phase 1 Study of Preoperative Gemcitabine Plus CP-870, 893 Followed by Addition of CP-870,893 to Standard -Of-care Adjuvant Chemoradiation for Patients With Newly Diagnosed Resectable Pancreatic Carcinoma

Who this might be right for
Adenocarcinoma Pancreas
Abramson Cancer Center at Penn Medicine 10
Testing effectiveness (Phase 2)UnknownNCT04216758
What this trial is testing

Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic Cancer

Who this might be right for
Stage IA Pancreatic AdenocarcinomaStage IB Pancreatic AdenocarcinomaStage IIA Pancreatic Adenocarcinoma+1 more
Fudan University 300
Not applicableLooking for participantsNCT05517811
What this trial is testing

Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection

Who this might be right for
Liver CancerEsophageal CancerColorectal Cancer+4 more
University of Colorado, Denver 400
Load More Results